Elaine Herrmann Blais

Elaine Blais, head of the Litigation Department in Goodwin’s Boston office, focuses her practice on intellectual property litigation, particularly patent litigation, and she is a member of the firm’s Life Sciences Disputes group. Ms. Blais has first-chaired numerous lawsuits and taken cases to trial in federal courts nationwide. She serves on Goodwin’s Executive Committee and on its Intellectual Property Steering and Attorney Development Committees. Ms. Blais is the co-founder and editor of the firm’s biosimilars blog, www.bigmoleculewatch.com, which is dedicated to providing resources and observations through Goodwin’s active watch of the world of biologics, biosimilars and the Biologics Price Competition and Innovation Act (BPCIA). She currently co-chairs the firm’s Dobbs Task Force and is the former co-chair of the Boston Women's Initiative Council. Having served on various committees across the firm, Ms. Blais is currently co-chair of our Incubator Committee, which guides the growth and development of emerging and innovative practices.